Stop blindly pursuing the nine-valent HPV vaccine| Beijing News Quick Review

The nine-valent HPV vaccine (nine-valent human papillomavirus vaccine) has been in short supply since it was launched in China in April 2018. According to the surging news report, in recent days, "a seedling is difficult to find" has spawned rampant scalpers, and even professional technical and business teams have emerged, involving robbery, fresh seedlings, smuggling port seedlings, etc. There are scalpers who bluntly say that the monthly income is tens of thousands.

The phenomenon of the nine-valent HPV vaccine has been robbed for several years, whether it is a lottery to send seedlings, win the lottery, or a rampant scalper, relying on this windfall, all reflect the degree of popularity of the nine-valent HPV vaccine. HPV vaccines have a short time on the market in China, and the consumer demand accumulated for many years is released centrally, and it is understandable that the supply exceeds demand for a time.

However, compared with 2018, the current situation has changed a lot, in the past HPV vaccines all rely on imports, last year's domestic bivalent HPV vaccines were listed, and now has the ability to mass production. Moreover, the domestic divalent HPV vaccine has recently been pre-certified by the World Health Organization, and the quality is not inferior to similar foreign products. A more important change is that at present, many places in the country have introduced a free HPV vaccination policy, mainly for girls of the right age to receive free bivalent vaccines.

Therefore, the public's cognition and attitude towards HPV vaccines may wish to keep pace with the times.

▲On June 14, 2019, the newly revised nine-valent cervical cancer vaccine was launched in the mainland. Photo / Beijing News our video screenshot

In addition, the medical community has also significantly strengthened the popularization and guidance of the public in this regard. For example, many experts have made it clear that after vaccination of bivalent and quadrivalent, as long as you want in the future, you can also replant nine valence. This is technically feasible, but it is not recommended for reasons such as cost performance and the fact that bivalent and quadrivalent HPV vaccines can produce sufficient protection.

If it is said that the previous nine-valent HPV vaccine was widely sought after, it is understandable, but with the passage of time, the current environment has the conditions to cool down the hot nine-valent HPV vaccine.

First of all, the timeliness of HPV vaccination is more important than the price, and early vaccination of bivalent and quadrivalent vaccines is more realistic and cost-effective than the nine-valent vaccine such as bitterness;

Second, different types of HPV vaccines have different age of application, with bivalent and quadrivalent applicable to 9 to 45 years old and nine valents applying to 16 to 26 years old.

If the public pays more attention to the timeliness of vaccination and follows the applicable age of different types of HPV vaccines, the phenomenon of "one vaccine is difficult to find" of nine-valent HPV vaccine is expected to be greatly alleviated.

A more rational approach is to leave the nine-valent HPV vaccine to the most appropriate age group, and other groups of people will be vaccinated with bivalent and quadrivalent vaccines first, and the possibility of "upgrading" will be retained later. What's more, the fourteen-valent HPV vaccine has entered the clinical phase II trial in China, and people who are currently pursuing the nine-valent HPV vaccine will have after the successful development and marketing of the fourteen-valent HPV vaccine? It is smart to get the HPV vaccine as soon as possible and reserve more possibilities for the future.

The shortage of the nine-valent HPV vaccine is a reality, but the more people who are scrambling, the effect of similar "hunger marketing" will be generated, resulting in the vaccine falling into an increasingly scarce circle. As soon as possible out of this dilemma, in addition to prompting production enterprises to accelerate production capacity adjustment, significantly increase the domestic supply of nine-valent HPV vaccine, the public should also see the changes that have occurred, and foresee the possible greater changes, take the initiative to adjust the mood, not blindly follow the crowd, do not chaos, while cooling down the nine-valent HPV vaccine, but also for their own psychological pressure.

Special Commentator | Tang Chuanyan (Doctor)

Edit | Li Xiaoxiao

Proofreading | Liu Jun